3/14
01:32 am
xgn
Low
Report
3/11
01:40 pm
xgn
Exagen (XGN) had its price target lowered by Canaccord Genuity Group Inc. from $15.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (XGN) had its price target lowered by Canaccord Genuity Group Inc. from $15.00 to $10.00. They now have a "buy" rating on the stock.
3/11
11:30 am
xgn
Exagen (XGN) had its price target lowered by Craig Hallum from $12.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (XGN) had its price target lowered by Craig Hallum from $12.00 to $10.00. They now have a "buy" rating on the stock.
3/11
09:44 am
xgn
Exagen (XGN) had its price target lowered by KeyCorp from $15.00 to $10.00. They now have an "overweight" rating on the stock.
Low
Report
Exagen (XGN) had its price target lowered by KeyCorp from $15.00 to $10.00. They now have an "overweight" rating on the stock.
3/11
05:02 am
xgn
Avolta AG GAAP EPS of CHF 1.36, revenue of CHF 13.76B [Seeking Alpha]
Medium
Report
Avolta AG GAAP EPS of CHF 1.36, revenue of CHF 13.76B [Seeking Alpha]
3/11
04:29 am
xgn
Earnings Snapshot: Groupon Q4 North America local revenue +4%, billings +9% [Seeking Alpha]
Medium
Report
Earnings Snapshot: Groupon Q4 North America local revenue +4%, billings +9% [Seeking Alpha]
3/10
06:56 pm
xgn
Exagen Inc. (XGN) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Exagen Inc. (XGN) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/10
06:52 pm
xgn
Exagen outlines $70M–$73M 2026 revenue target while expanding sales force and innovation cadence [Seeking Alpha]
Medium
Report
Exagen outlines $70M–$73M 2026 revenue target while expanding sales force and innovation cadence [Seeking Alpha]
3/10
05:03 pm
xgn
Exagen Inc (XGN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Investments [Yahoo! Finance]
Medium
Report
Exagen Inc (XGN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Investments [Yahoo! Finance]
3/10
04:28 pm
xgn
Groupon GAAP EPS of $0.17 beats by $0.03, revenue of $132.7M misses by $3.87M [Seeking Alpha]
Low
Report
Groupon GAAP EPS of $0.17 beats by $0.03, revenue of $132.7M misses by $3.87M [Seeking Alpha]
3/10
03:37 pm
xgn
Exagen (XGN) had its price target lowered by BTIG Research from $10.00 to $9.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (XGN) had its price target lowered by BTIG Research from $10.00 to $9.00. They now have a "buy" rating on the stock.
3/10
03:02 pm
xgn
Exagen (XGN) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Exagen (XGN) had its "outperform" rating reaffirmed by William Blair.
3/10
11:41 am
xgn
Exagen Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Exagen Q4 Earnings Call Highlights [Yahoo! Finance]
3/10
08:32 am
xgn
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results [Yahoo! Finance]
Low
Report
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results [Yahoo! Finance]
3/10
08:00 am
xgn
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
Medium
Report
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
3/5
12:51 pm
xgn
Bioventus Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Bioventus Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/3
09:00 am
xgn
Exagen Inc. to Participate in Upcoming Investor Conferences
Low
Report
Exagen Inc. to Participate in Upcoming Investor Conferences
2/24
12:30 pm
xgn
Exagen (NASDAQ:XGN) had its price target lowered by analysts at TD Cowen from $13.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target lowered by analysts at TD Cowen from $13.00 to $10.00. They now have a "buy" rating on the stock.
2/24
09:41 am
xgn
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 [Yahoo! Finance]
Neutral
Report
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 [Yahoo! Finance]
2/24
09:00 am
xgn
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
Low
Report
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
2/17
08:03 am
xgn
Exagen (NASDAQ:XGN) had its price target lowered by analysts at BTIG Research from $15.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target lowered by analysts at BTIG Research from $15.00 to $10.00. They now have a "buy" rating on the stock.
1/30
09:03 am
xgn
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $8.00 price target on the stock, down previously from $18.00.
Medium
Report
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $8.00 price target on the stock, down previously from $18.00.
1/27
05:32 pm
xgn
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target [Yahoo! Finance]
Medium
Report
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target [Yahoo! Finance]
1/12
01:38 pm
xgn
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story [Yahoo! Finance]
Low
Report
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story [Yahoo! Finance]
1/11
03:18 pm
xgn
Exagen Inc. Announces Select Preliminary 2025 Financial Results [Yahoo! Finance]
Medium
Report
Exagen Inc. Announces Select Preliminary 2025 Financial Results [Yahoo! Finance]